Market Estimates
Valuation Metrics
Financials
Trading Trends
AUPH News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Aurinia Pharmaceuticals Inc (AUPH) stock price today?
The current price of AUPH is 15.15 USD — it has decreased -1.17 % in the last trading day.
What is Aurinia Pharmaceuticals Inc (AUPH)'s business?
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.
What is the price predicton of AUPH Stock?
Wall Street analysts forecast AUPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AUPH is 16.50 USD with a low forecast of 13.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Aurinia Pharmaceuticals Inc (AUPH)'s revenue for the last quarter?
Aurinia Pharmaceuticals Inc revenue for the last quarter amounts to 73.47M USD, increased 8.41 % YoY.
What is Aurinia Pharmaceuticals Inc (AUPH)'s earnings per share (EPS) for the last quarter?
Aurinia Pharmaceuticals Inc. EPS for the last quarter amounts to 0.23 USD, increased 130.00 % YoY.
What changes have occurred in the market's expectations for Aurinia Pharmaceuticals Inc (AUPH)'s fundamentals?
How many employees does Aurinia Pharmaceuticals Inc (AUPH). have?
Aurinia Pharmaceuticals Inc (AUPH) has 130 emplpoyees as of January 09 2026.
What is Aurinia Pharmaceuticals Inc (AUPH) market cap?
Today AUPH has the market capitalization of 2.00B USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F7ed2f4fd51e534e857c4c99845be21e761b8a9d39d6f97cc89ce7ad2ff2e20b8.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Fa804be1d0e6498f8b45d38cdf3a220d58869348bd8a1c262f324169816907775.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Fee4cef50e7ae97bb1cbdc728b411ad688a279fbeb678a6dc1b66b0ed33d2cae4.jpg&w=384&q=75)